TARSUS PHARMACEUTICA (TARS) insider trading activity (SEC Form 4). Over the trailing 90 days, TARS insiders filed 0 purchases totalling $0 and 4 sales totalling $2.5M — net SELLING of $2.5M. Most recent filing: Jun 22, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | Azamian Bobak R. | Pres, CEO, Board Chair | S Sale | — | $61.55 | $615K | filing |
| Jun 17, 2026 | Farrow Jeffrey S | See Remarks | S SaleOE | — | $60.95 | $877K | filing |
| Jun 17, 2026 | Link William J Phd | Dir | S Sale | — | $62.12 | $776K | filing |
| Jun 17, 2026 | Goodrich Katherine | Dir | S Sale | — | $62.08 | $183K | filing |